The risk for cardiac events, though not well defined, should not hold up marketing, said the FDA panel members. Medscape Medical News …read more January 17, 2019Post navigationPreviousPrevious post:Repeat Procedure Risk Increased With Essure ContraceptiveNextNext post:Let’s Reassure Women About the Safety of Vaginal Estrogen
